Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Nanoparticulate Delivery of Cancer Cell Membrane Elicits Multiantigenic Antitumor Immunity.

Kroll AV, Fang RH, Jiang Y, Zhou J, Wei X, Yu CL, Gao J, Luk BT, Dehaini D, Gao W, Zhang L.

Adv Mater. 2017 Dec;29(47). doi: 10.1002/adma.201703969. Epub 2017 Nov 2.

PMID:
29239517
2.

Nanoparticle Functionalization with Platelet Membrane Enables Multifactored Biological Targeting and Detection of Atherosclerosis.

Wei X, Ying M, Dehaini D, Su Y, Kroll AV, Zhou J, Gao W, Fang RH, Chien S, Zhang L.

ACS Nano. 2018 Jan 23;12(1):109-116. doi: 10.1021/acsnano.7b07720. Epub 2017 Dec 12.

PMID:
29216423
3.

Remote Loading of Small-Molecule Therapeutics into Cholesterol-Enriched Cell-Membrane-Derived Vesicles.

Zhang X, Angsantikul P, Ying M, Zhuang J, Zhang Q, Wei X, Jiang Y, Zhang Y, Dehaini D, Chen M, Chen Y, Gao W, Fang RH, Zhang L.

Angew Chem Int Ed Engl. 2017 Nov 6;56(45):14075-14079. doi: 10.1002/anie.201707598. Epub 2017 Oct 5.

PMID:
28892588
4.

Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization.

Dehaini D, Wei X, Fang RH, Masson S, Angsantikul P, Luk BT, Zhang Y, Ying M, Jiang Y, Kroll AV, Gao W, Zhang L.

Adv Mater. 2017 Apr;29(16). doi: 10.1002/adma.201606209. Epub 2017 Feb 15.

5.

Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia.

Wei X, Gao J, Fang RH, Luk BT, Kroll AV, Dehaini D, Zhou J, Kim HW, Gao W, Lu W, Zhang L.

Biomaterials. 2016 Dec;111:116-123. doi: 10.1016/j.biomaterials.2016.10.003. Epub 2016 Oct 5.

6.

Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery.

Dehaini D, Fang RH, Luk BT, Pang Z, Hu CM, Kroll AV, Yu CL, Gao W, Zhang L.

Nanoscale. 2016 Aug 14;8(30):14411-9. doi: 10.1039/c6nr04091h. Epub 2016 Jul 14.

7.

Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant Staphylococcus aureus Skin Infection.

Wang F, Fang RH, Luk BT, Hu CJ, Thamphiwatana S, Dehaini D, Angsantikul P, Kroll AV, Pang Z, Gao W, Lu W, Zhang L.

Adv Funct Mater. 2016 Mar 8;26(10):1628-1635. Epub 2016 Feb 5.

8.

Biomimetic strategies for targeted nanoparticle delivery.

Dehaini D, Fang RH, Zhang L.

Bioeng Transl Med. 2016 May 27;1(1):30-46. doi: 10.1002/btm2.10004. eCollection 2016 Mar. Review.

9.

Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors.

Luk BT, Fang RH, Hu CM, Copp JA, Thamphiwatana S, Dehaini D, Gao W, Zhang K, Li S, Zhang L.

Theranostics. 2016 Apr 28;6(7):1004-11. doi: 10.7150/thno.14471. eCollection 2016.

10.

Nanoparticle biointerfacing by platelet membrane cloaking.

Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, Nguyen P, Angsantikul P, Wen CH, Kroll AV, Carpenter C, Ramesh M, Qu V, Patel SH, Zhu J, Shi W, Hofman FM, Chen TC, Gao W, Zhang K, Chien S, Zhang L.

Nature. 2015 Oct 1;526(7571):118-21. doi: 10.1038/nature15373. Epub 2015 Sep 16.

11.

Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles.

Luk BT, Hu CM, Fang RH, Dehaini D, Carpenter C, Gao W, Zhang L.

Nanoscale. 2014 Mar 7;6(5):2730-7. doi: 10.1039/c3nr06371b. Epub 2014 Jan 27.

12.

Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release.

Aryal S, Hu CM, Fang RH, Dehaini D, Carpenter C, Zhang DE, Zhang L.

Nanomedicine (Lond). 2013 Aug;8(8):1271-80. doi: 10.2217/nnm.12.153. Epub 2013 Feb 14.

PMID:
23409747

Supplemental Content

Loading ...
Support Center